These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 25205367

  • 1. Place conditioning to apomorphine in rat models of Parkinson's disease: differences by dose and side-effect expression.
    Campbell JC, Jeyamohan SB, De La Cruz P, Chen N, Shin D, Pilitsis JG.
    Behav Brain Res; 2014 Dec 15; 275():114-9. PubMed ID: 25205367
    [Abstract] [Full Text] [Related]

  • 2. Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
    Riddle JL, Rokosik SL, Napier TC.
    Behav Brain Res; 2012 Jul 15; 233(1):15-23. PubMed ID: 22727039
    [Abstract] [Full Text] [Related]

  • 3. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Metz GA, Tse A, Ballermann M, Smith LK, Fouad K.
    Eur J Neurosci; 2005 Aug 15; 22(3):735-44. PubMed ID: 16101755
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.
    Petri D, Pum M, Vesper J, Huston JP, Schnitzler A.
    Behav Brain Res; 2013 Sep 01; 252():58-67. PubMed ID: 23727148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
    Machado-Filho JA, Correia AO, Montenegro AB, Nobre ME, Cerqueira GS, Neves KR, Naffah-Mazzacoratti Mda G, Cavalheiro EA, de Castro Brito GA, de Barros Viana GS.
    Behav Brain Res; 2014 May 01; 264():116-25. PubMed ID: 24525422
    [Abstract] [Full Text] [Related]

  • 14. Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion.
    Hsieh TH, Chen JJ, Chen LH, Chiang PT, Lee HY.
    Behav Brain Res; 2011 Sep 12; 222(1):1-9. PubMed ID: 21435355
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM, Saravanan KS, Mohanakumar KP.
    Brain Res; 2005 Jul 27; 1051(1-2):25-34. PubMed ID: 15992782
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
    Matsukawa N, Maki M, Yasuhara T, Hara K, Yu G, Xu L, Kim KM, Morgan JC, Sethi KD, Borlongan CV.
    Brain Res; 2007 Jul 30; 1160():113-23. PubMed ID: 17573046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.